Results 11 to 20 of about 19,997 (254)
Genetic background of RhD negative blood donors
Objective To analyze the genetic background of RhD-negative blood donors by detecting RHD and RHCE genes of those donors. Methods From March 2021 to May 2022, the blood samples of RhD-negative blood donors, who had been screened out by RhD primary ...
Qi REN +8 more
doaj +2 more sources
ABO and RhD Blood Groups in Nasal Polyposis [PDF]
Objective:The aim of this study was to determine ABO and RhD blood group distribution in nasal polyposis (NP) patients and whether there is a specific ABO or RhD blood phenotype associated with susceptibility to or protection with respect to development ...
Boris Jelavic +5 more
doaj +2 more sources
A real-time PCR-based noninvasive prenatal RHD screening assay optimized for population-specific RHD allelic spectra in China [PDF]
Background Prenatal RhD screening enables risk stratification for RhD-associated hemolytic disease of the fetus and newborn (HDFN) and supports rational,evidence-based use of prophylactic anti-RhD immunoglobulin.
Xiang Wei, Linzhi Jiang, Qian Zhu
doaj +2 more sources
Genetic diversity of the [PDF]
Introduction: The Rh blood group system is recognized for its complexity and its clinical importance in transfusion medicine. Antibodies against Rh antigens are associated with hemolytic transfusion reactions, autoimmune hemolytic anemia, and hemolytic ...
Ana Luisa Alves Mafra +8 more
doaj +2 more sources
Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis–an external quality assessment workshop [PDF]
Background and Objectives: Fetal RHD genotyping of cell-free fetal DNA from RhD-negative pregnant women can be used to guide targeted antenatal and postnatal anti-D prophylaxis for the prevention of RhD immunization.
Noninvasive Fetal RHD Genotyping EQA2017 Working Group +2 more
core +4 more sources
Introduction: Targeted routine antenatal prophylaxis with anti-D immunoglobulin (Ig) only to RhD-negative pregnant women who carry RhD-positive fetuses (determined by fetal RHD genotyping) has reduced D-alloimmunization significantly when administered in
Tonje Espeland Bagås +31 more
core +1 more source
Cost Evaluation of Fetal Rhesus D Genotyping by Real-time PCR from cell-free Fetal DNA
The detection of cell-free fetal DNA (cffDNA) from maternal plasma has enabled the development of essential prenatal diagnostic techniques supporting the non-invasive screening and diagnostic tests in recent years.
Büşra Yaşa Çevik +2 more
doaj +1 more source
PREVENTION OF RhD ALLOIMMUNIZATION IN RhD NEGATIVE WOMEN [PDF]
Despite the introduction of anti-D prophylaxis into clinical practice, RhD alloimmunization still presents a problem to date. The actual incidence of RhD alloimmunization in pregnant women remains unknown in most countries. Anti-D immunoglobulin is administered to RhD negative women at a fixed dose and in much greater amounts than is actually necessary.
openaire +2 more sources
VariantRHDTypes in Brazilians With Discrepancies in RhD Typing [PDF]
BackgroundThe knowledge of D variants in patients and donors is important because anti‐D alloimmunization can occur in some but not all individuals who express a variantRHDallele. Serologic distinction of RhD discrepancies is not always straightforward, which makes molecular analysis highly desirable.MethodsA group of 223 subjects, 129 patients, and 94
Fernanda Carolina Alves, Campos +6 more
openaire +2 more sources
Noninvasive prenatal diagnosis of fetal RhD status using cell-free fetal DNA in maternal plasma with TaqMan® real-time PCR assay [PDF]
Prenatal diagnosis is now part of established obstetric practice in many countries. However, conventional methods of prenatal diagnosis of obtaining fetal tissues for genetic analysis, including amniocentesis and chorionic villus sampling, are invasive
Rekhviashvili, Tea
core +1 more source

